T. Toliou

Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy

Vassiliki Malamou‐Mitsi, Helen Gogas, Urania Dafni et al. · Annals of Oncology · 2006 · 51 citations · Full text

Medicine, Oncology, Breast Oncology +13

Evaluation of the prognostic value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy (DSAC)

Dimosthenis Skarlos, Helen Gogas, V. Kiriakou et al. · Journal of Clinical Oncology · 2005 · 19 citations

Medicine, Oncology, Breast Oncology +14

Significant Experimental Decrease of the Hepatocellular Carcinoma Incidence in C₃H/Sy Mice After Long-Term Administration of EB1089, a Vitamin D Analogue

D. Sahpazidou, P. Stravoravdi, T. Toliou et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2003 · 17 citations · Full text

Medicine, Oncology, Pharmacology +14

Effect of Navelbine on Inhibition of Tumor Growth, Cellular Differentiation and Estrogen Receptor Status on Lewis Lung Carcinoma

Anastassios C. Papageorgiou, P. Stravoravdi, D. Sahpazidou et al. · Chemotherapy · 2000 · 15 citations

Medicine, Oncology, Pharmacology +17

Natural killer cell activation after interferon administration in patients with metastatic renal cell carcinoma: an ultrastructural and immunohistochemical study.

T. Toliou, P. Stravoravdi, M Polyzonis et al. · PubMed · 1996 · 13 citations

Life Sciences, Immunology, Oncology +17